Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001641172-25-002983
Filing Date
2025-04-07
Accepted
2025-04-07 16:05:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6435
  Complete submission text file 0001641172-25-002983.txt   8278
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Subject) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-78472 | Film No.: 25818141
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 3 COLUMBUS CIRCLE FLOOR 15 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE FLOOR 15 NEW YORK NY 10019 212-309-7664
Lagoda Investment Management, L.P. (Filed by) CIK: 0001632108 (see all company filings)

EIN.: 464740139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A